Newshawk TimeStem Cell Market in United States Report: Price Trend of Key Raw Materials, Type and Applications Forecasted by 2022Newshawk TimeStem Cell Market in United States analysis is provided for global market including development trends by regio… Continue reading
Pulmonary Hypertension News |
Mount Sinai, Theragene Form Partnership to Move Potential PH Gene Therapy to Clinical Development
Pulmonary Hypertension News New York’s Mount Sinai and Theragene Pharmaceuticals have joined efforts to move a novel investigational aerosol-delivered gene therapy to treat pulmonary hypertension (PH) into a clinical development program. The new therapy, if approved, will be the … |
Pulmonary Hypertension News |
Mount Sinai, Theragene Form Partnership to Move Potential PH Gene Therapy to Clinical Development
Pulmonary Hypertension News New York’s Mount Sinai and Theragene Pharmaceuticals have joined efforts to move a novel investigational aerosol-delivered gene therapy to treat pulmonary hypertension (PH) into a clinical development program. The new therapy, if approved, will be the … |
The Independent |
Leukaemia patient whose sister had UK visa refused for stem cell transplant dies
The Independent A woman whose sister was refused entry to the UK to donate her “perfect match” bone marrow has died from leukaemia. May Brown, 24, was told she needed an urgent stem cell transplant last year. But her sister, Martha Brown, was blocked from travelling … Woman who needed stem cell treatment dies after sister was … – MetroMetro May Brown: Visa battle transplant sister dies – BBC NewsBBC News Forever in our hearts: Young mum May Brown dies in hospital (From …Dorset Echo |
News-Medical.net |
Developing software for cell and gene therapy supply chain tracking
News-Medical.net What are the main challenges in logistics and supply chain management in the cell therapy industry? The first thing is, to always remember that we’re dealing with a living drug, cells, which are very sensitive to environmental conditions, such as … |
News@Northeastern |
What makes cancer gene therapy so groundbreaking?
News@Northeastern CAR–T cell, or chimeric antigen receptor T-cell therapy, is one of the newer treatment options for cancer. It’s based on the patient’s own immune system. In this approach, the patient’s T-cells are harvested and then genetically modified outside the … |